Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...
Alumis Inc. upgraded to Buy on strong Phase 3 psoriasis data for envudeucitinib, NDA plans, and upside valuation. Click here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results